Portfolio

Endologix

Develops and manufactures minimally invasive treatments for vascular diseases


Endologix (Nasdaq:  ELGX) develops innovative medical devices for the treatment of aortic abdominal aortic aneurysms.  In 2010, Essex Woodlands made an investment in Endologix, concurrently selling its other portfolio company, Nellix Endovascular, to Endologix.